http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105214090-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2015-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105214090-B
titleOfInvention A kind of Fe3O4The synthetic method of@ZnO core-shell nanospheres
abstract The invention discloses a kind of Fe 3 O 4 The synthetic method of@ZnO core-shell nanospheres.The present invention passes through diethylene glycol (DEG), diethanol amine and Fe 2+ And Fe 3+ With aqueous slkali coprecipitation reaction after being complexed, superparamagnetism Fe is prepared 3 O 4 Nanosphere.Fe 3 O 4 The dispersed rear and Zn of nanosphere 2+ It is sufficiently mixed with the complex solution of diethylene glycol (DEG), diethanol amine, adds aqueous slkali that coprecipitation reaction occurs.Instant invention overcomes nanosphere size in the prior art to be difficult to control, and disperses inequality, Fe 3 O 4 The defects of being difficult to form good spherical nucleocapsid material with ZnO.Fe 3 O 4 @ZnO core-shell nanospheres specific surface area is big, uniform particle diameter, pattern is adjustable, it is good to carry drug effect fruit.The Fe prepared in the present invention 3 O 4 @ZnO core-shell nanospheres can effectively antagonize cancer drug daunorubicin and be carried and be sustained, and can carry out target administration, and can carry out phototherapy.The present invention simple synthetic method is easy, target administration, phototherapy effect is good, toxicity is low, there is wide clinical medicine application value and prospect.
priorityDate 2015-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009017525-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453265332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451326926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452506218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447773061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8117

Total number of triples: 44.